ABOS
Price
$1.10
Change
-$0.01 (-0.90%)
Updated
Apr 14 closing price
Capitalization
67.24M
35 days until earnings call
NAUT
Price
$0.78
Change
-$0.01 (-1.27%)
Updated
Apr 14 closing price
Capitalization
98.66M
21 days until earnings call
Ad is loading...

ABOS vs NAUT

Header iconABOS vs NAUT Comparison
Open Charts ABOS vs NAUTBanner chart's image
Acumen Pharmaceuticals
Price$1.10
Change-$0.01 (-0.90%)
Volume$172.6K
Capitalization67.24M
Nautilus Biotechnolgy
Price$0.78
Change-$0.01 (-1.27%)
Volume$150.5K
Capitalization98.66M
ABOS vs NAUT Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. NAUT commentary
Apr 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and NAUT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 15, 2025
Stock price -- (ABOS: $1.10 vs. NAUT: $0.78)
Brand notoriety: ABOS and NAUT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 76% vs. NAUT: 98%
Market capitalization -- ABOS: $67.24M vs. NAUT: $98.66M
ABOS [@Biotechnology] is valued at $67.24M. NAUT’s [@Biotechnology] market capitalization is $98.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $281.29B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • NAUT’s FA Score: 1 green, 4 red.
According to our system of comparison, NAUT is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 6 TA indicator(s) are bullish while NAUT’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 6 bullish, 2 bearish.
  • NAUT’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than NAUT.

Price Growth

ABOS (@Biotechnology) experienced а +4.76% price change this week, while NAUT (@Biotechnology) price change was -2.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.53%. For the same industry, the average monthly price growth was -13.77%, and the average quarterly price growth was -22.20%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

NAUT is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+4.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAUT($98.7M) has a higher market cap than ABOS($67.2M). ABOS YTD gains are higher at: -36.047 vs. NAUT (-53.446). NAUT (-75.12M) and ABOS (-77.89M) have comparable annual earnings (EBITDA) . ABOS has more cash in the bank: 200M vs. NAUT (130M). ABOS has less debt than NAUT: ABOS (28.5M) vs NAUT (30.5M). ABOS (0) and NAUT (0) have equivalent revenues.
ABOSNAUTABOS / NAUT
Capitalization67.2M98.7M68%
EBITDA-77.89M-75.12M104%
Gain YTD-36.047-53.44667%
P/E RatioN/AN/A-
Revenue00-
Total Cash200M130M154%
Total Debt28.5M30.5M93%
FUNDAMENTALS RATINGS
NAUT: Fundamental Ratings
NAUT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSNAUT
RSI
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 5 days ago
84%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 5 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
83%
Advances
ODDS (%)
Bullish Trend 23 days ago
77%
Bullish Trend 30 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
84%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
82%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QIND0.03N/A
+8.12%
Quality Industrial Corp.
PALAF2.990.09
+3.28%
Paladin Energy Ltd.
BNPQY38.960.73
+1.91%
BNP Paribas
YAHOY7.230.10
+1.40%
LY Corporation
CZMWY63.790.82
+1.30%
Carl Zeiss Meditec AG

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-0.90%
FHTX - ABOS
55%
Loosely correlated
+4.06%
ATOS - ABOS
54%
Loosely correlated
-1.80%
BEAM - ABOS
50%
Loosely correlated
+9.89%
GBIO - ABOS
50%
Loosely correlated
-3.43%
ALEC - ABOS
50%
Loosely correlated
+3.24%
More

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-1.13%
FHTX - NAUT
52%
Loosely correlated
+4.06%
KYMR - NAUT
51%
Loosely correlated
+5.43%
TECH - NAUT
50%
Loosely correlated
+3.58%
ABOS - NAUT
46%
Loosely correlated
-0.90%
RLAY - NAUT
44%
Loosely correlated
+6.20%
More